Fareed, K R <br/><br/>
Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy.  [electronic resource] 

 -  British journal of cancer  May 2010 
 - 1600-7 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>1532-1827 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjc.6605686  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--diagnosis<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biomarkers, Pharmacological--analysis<br/>Biomarkers, Tumor--metabolism<br/>Cell Nucleus--metabolism<br/>Cell Proliferation<br/>DNA-Binding Proteins--metabolism<br/>Endonucleases--metabolism<br/>Esophageal Neoplasms--diagnosis<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Platinum Compounds--administration & dosage<br/>Prognosis<br/>Stomach Neoplasms--diagnosis<br/>Survival Analysis<br/>Tissue Array Analysis<br/>Treatment Outcome<br/>Tumor Burden--physiology